Ambient Biosciences

About

Ambient Biosciences is a biomolecule stabilization technology company based in Ann Arbor, Michigan, founded in 2014. The company focuses on innovative solutions that allow for the ambient temperature storage and transportation of biomolecules, eliminating the need for cold chain logistics in the life sciences sector. The core technology of Ambient Biosciences is capillary-assisted vitrification (CAV), which offers a freeze-free method for creating shelf-stable reagents. This process is faster and more cost-effective than traditional lyophilization, making it applicable across various biomolecule classes. The company stabilizes a wide range of biomolecules, including antibodies, enzymes, DNA/RNA, small molecules, and cells, significantly extending their shelf life and improving laboratory efficiency. Ambient Biosciences collaborates with notable organizations in the life sciences field, including AssayQuant Technologies and Vanderbilt University, to enhance product stability and reduce cold chain requirements. The company is currently in the Series A-II funding stage, having raised over $24 million to support its mission of improving global health equity through biotechnology innovation.